The levels of prothrombotic and inflammatory markers
| Investigated parameters | RA (n=37) | Control group (n=28) | P (M-U) |
|---|---|---|---|
| Me (25; 75‰) | Me (25; 75‰) | ||
| PLT, x109/l | 278,0 (221,0; 344,0) | 230,0 (205,0; 268,0) | 0,007* |
| APTP, s | 29,0 (27,0; 31,8) | 27,6 (26,5; 32,2) | 0,368 |
| Fibrinogen, g/l | 4,10 (3,67; 5,10) | 3,10 (2,84; 3,78) | 0,0006* |
| D-Dimer, ng/ml | 371,31 (95,99; 1163,08) | 50,82 (27,72; 88,80) | 0,00003* |
| LA | 1,22 (1,13; 1,38) | 1,04 (0,81; 1,16) | 0,007* |
| aCL IgG, U/ml | 36,60 (26,20; 49,75) | 13,51 (10,26; 15,39) | <0,0001* |
| aCL IgM, U/ml | 22,90 (16,54; 50,74) | 15,15; 7,89; 27,00) | 0,002* |
| aβ2-GP1 IgG, U/ml | 4,29 (2,39; 9,40) | 3,96 (3,43; 5,33) | 0,781 |
| aβ2-GP1 IgM, U/ml | 2,70 (1,82; 4,43) | 1,88 (1,42; 2,25) | 0,007* |
| hs-CRP, g/l | 11,41 (3,45; 18,00) | 1,15 (0,57; 1,90) | <0,0001* |
| IL-6, pg/ml | 11,48 (7,99; 31,14) | 0,66 (0,23; 0,84) | <0,0001* |
| TNF-α, pg/ml | 1,39 (0,41; 2,69) | 0,00 (0,00; 0,00) | 0,0002* |